





Sunita R. Jha 
BMedSci (Hons) 
 
This thesis is presented in the fulfilment of the Degree of 
Doctor of Philosophy 
 
University of Technology Sydney, 
(07/07/2017) 
 
Frailty in patients with advanced 
heart failure referred for heart 
transplantation 
2
Certificate of original authorship
I certify that the work in this thesis has not previously been submitted for a degree 
nor has it been submitted as part of requirements for a degree except as fully 
acknowledged within the text. I also certify that the thesis has been written by me. 
Any help that I have received in my research work and the preparation of the thesis 
itself has been acknowledged. In addition, I certify that all information sources and 





This research is supported by an Australian Government Research Training Program 
Scholarship.
Production Note:




“The 10 years from 18 to 28 comprise the most pivotal decade in a person’s life.” 
- Mintz, S. (2015). The Prime of Life. Harvard University Press. 
 
Having spent a good portion of my most pivotal years undertaking this PhD, the 
mentors, supervisors, colleagues, relationships and friends I’ve made during this time 
will have untold influence on my life. 
This project has been a privilege and my gratitude extents mostly towards those 
responsible for letting me do it – my supervisors: Professor Peter Macdonald for your 
genuine mentorship and time and Professor Philip Newton for your constant 
friendship; with an ever generous hand from Dr Caleb Ferguson and Associate 
Professor Louise Hickman. I’d also like to extend my gratitude towards those apart of 
the Centre for Cardiovascular and Chronic Care (UTS-CCCC), namely Associate 
Professor Michelle DiGiacomo, Dr Tim Luckett and Professor Patricia Davidson for 
fostering a positive academic home for young researchers like myself. 
I’d also like to acknowledge the support of my fellow PhD colleagues, especially Serra 
Ivynian, Domenica Disalvo and Anna Green, whose friendships will exist far beyond 
our “PhD days”. 













Anthology of publications and presentations  
As our research group at St. Vincent’s hospital were the first to investigate the impact 
of frailty in patient’s referred for heart transplantation, our work was met with keen 
interest both nationally and internationally. As frailty is commonly recognised, yet 
poorly understood within the clinical setting of advanced heart failure, there was a real 
desire within the transplant community for our team to proactively communicate our 
findings as they emerged. Accordingly, over the course of this PhD we were fortunate 
enough to publish the findings in several highly reputable journals and present 
numerous abstracts across several prestigious conferences. As part of this thesis, there 
were a total of 4 associated publications and 16 presented abstracts (10 oral: 6 poster), 
listed below. 
Publications associated with this thesis 
Sunita R Jha, Malin K Hannu, Phillip J Newton, Kay Wilhelm, Christopher S 
Hayward, Andrew Jabbour, Eugene Kotlyar, Anne Keogh, Kumud Dhital, Emily 
Granger, Mark Connellan, Paul Jansz, Phillip M Spratt, Elyn Montgomery, Angela 
Smith, Michelle Harkess, Peta Tunicliff, Patricia M Davidson, Peter S Macdonald. 
Reversibility of frailty after bridge-to-transplant ventricular assist device implantation 
or heart transplantation. Transplantation Direct. 2017:3(7). [Impact factor: 3.535; 
citations: 8] 
Sunita R Jha, Malin K Hannu, Keren Gore, Sungwon Chang, Phillip Newton, Kay 
Wilhelm, Christopher S Hayward, Andrew Jabbour, Eugene Kotlyar, Anne Keogh, 
Kumud Dhital, Emily Granger, Paul Jansz, Phillip M Spratt, Elyn Montgomery, 
Michelle Harkess, Peta Tunicliff, Patricia M Davidson, Peter S Macdonald. Cognitive 
impairment improves the predictive validity of physical frailty for mortality in patients 
with advanced heart failure referred for heart transplantation. Journal of Heart and 
Lung Transplantation. 2016:35(9):1092-100. [Impact factor: 7.509; citations: 21] 
Sunita R Jha, Malin K Hannu, Sungwon Chang, Elyn Montgomery, Michelle 
Harkess, Kay Wilhelm, Christopher S Hayward, Andrew Jabbour, Phillip M Spratt, 
Phillip Newton, Patricia M Davidson, Peter S Macdonald. The prevalence and 
prognostic significance of frailty in patients with advanced heart failure referred for 
heart transplantation. Transplantation. 2016:100(2):429-36. [Impact factor: 3.690; 
citations: 36] 
Sunita R Jha, Hakeem SK Ha, Louise D Hickman, Malin Hannu, Patricia M 
Davidson, Peter S Macdonald, Phillip J Newton. Frailty in advanced heart failure: A 




Accepted abstracts for oral presentation as part of this thesis 
Jha, S.R. et. al., Reversibility of Fried’s Physcial Frailty domains post- heart 
transplant among patients with advanced heart failure. Journal of Heart and Lung 
Transplantation. International Society of Heart and Lung Transplant (ISHLT), 
2018:37(4):S128. Nice, France.  
Jha, S.R. et. al., The Impact of Cognitive Frailty on Post-Bridge-to-Transplant 
Ventricular Assist Device (VAD) Outcomes. Journal of Heart and Lung 
Transplantation. International Society of Heart and Lung Transplant (ISHLT), 2018: 
37(4):S128-S129. Nice, France. 
Jha, S.R. et. al., Changes in Fried’s frailty domains post- ventricular-assist device 
implantation and heart transplantation. European Society of Cardiology – Heart 
Failure (ESC-HF), 2017. Paris, France. 
Jha, S.R. et. al., Reversibility of Frailty Post-VAD Implantation and Heart 
Transplantation. Heart, Lung and Circulation, 2016:25:S120, Cardiac Society of 
Australia and New Zealand (CSANZ), Adelaide, Australia. 
Jha, S.R. et. al., Cognitive Frailty in Heart-Transplant Eligible Patients: A Better 
Predictor of Mortality. Heart, Lung and Circulation, 2016:25:S120, Cardiac Society 
of Australia and New Zealand (CSANZ), Adelaide, Australia. 
Jha, S.R. et. al., Frailty Measures in Advanced Heart Failure Patients Listed for 
Transplantation. The Journal of Heart and Lung Transplantation, 2016:35(4):S27. 
International Society of Heart and Lung Transplant (ISHLT), 2016. Washington, 
USA. 
Jha, S.R. et. al., Reversibility of Frailty in Advanced Heart Failure Patients Listed for 
Transplantation. The Journal of Heart and Lung Transplantation, 2016:35(4):S27. 
International Society of Heart and Lung Transplant (ISHLT), 2016. Washington, 
USA. 
Jha, S.R. et. al., The inclusion of cognitive impairment to physical frailty improves 
survival prediction in heart transplant referred patients. Transplant Society of 
Australia and New Zealand Annual Scientific Meeting (TSANZ -ASM) – President’s 
Prize Session, 2016. Sydney, Australia. 
Jha, S.R. et. al., The reversibility of frailty in heart transplant listed patients. 
Transplant Society of Australia and New Zealand Annual Scientific Meeting (TSANZ 
-ASM), 2016. Sydney, Australia. 
Hannu, M., Jha, S.R. (presenter) et. al., Inclusion of Cognitive and Mood Domains in 
the Assessment of Frailty Enhances Outcome Prediction in Patients Undergoing 
Ventricular Assist Device Implantation. Journal of Heart and Lung Transplantation. 
International Society of Heart and Lung Transplant (ISHLT), 2015. Nice, France. 
 
 7 
Accepted abstracts for poster presentation as part of this thesis 
Jha, S.R. et. al., Changes in Fried’s frailty domains post- ventricular-assist device 
implantation and heart transplantation. Journal of Frailty and Ageing, ICFSR 2017. 
Barcelona, Spain.  
Jha, S.R., et. al., The inclusion of cognitive impairment to physical frailty improves 
survival prediction in heart transplant referred patients. Journal of Frailty and Ageing. 
2016:5(1). ICFSR, Philadelphia, USA.   
Jha, S.R., et. al., The reversibility of frailty in heart transplant listed patients. Journal 
of Frailty and Ageing. 2016:5(1). ICFSR, Philadelphia, USA.   
Jha, S.R. et. al., Does the inclusion of depression and cognitive screening to frailty 
assessment improve prediction of outcomes in heart transplant-eligible patients?, 
European Heart Journal. 2015(36):500. European Society of Cardiology (ESC) 2015. 
London, UK.  
Jha, S.R., et. al. Frailty as a Predictor of Outcomes in Heart Transplant-Eligible 
Patients With Advanced Heart Failure. Journal of Heart and Lung Transplantation. 
4(34):S187-S8 (ISHLT) 2015. Nice, France. 
Jha, S.R., et. al. Inclusion of Cognitive and Mood Domains in the Assessment of 
Frailty Enhances Outcome Prediction in Heart Transplant-Eligible Patients With 
Advanced Heart Failure. Journal of Heart and Lung Transplantation. 4(34):S181 







Abstracts accepted for oral presentation (N=10) are attached as Appendix 4.  





Rita P, Serenelli M, Bugani G, Tonet E, Celis-Morales C, Gray S, Izawa KP, Colin-Ramirez 
E, Lilia CM, Izumiya Y, Hanatani S, Onoue Y, Tsujita K, Macdonald PS, Jha SR, Roger V, 
Manemann S, McNallan SM, Sanchis J, Ruiz V, Ferrari R, Volpato S & Campo G. Grip 
Strength Predicts Cardiac Death and Hospital readmission for Heart Failure in Patients with 
Cardiac Disease: a Meta-analysis. JACC: Heart failure 2018. [under revision]. 
Mauthner, O., Claes, V., Jha, S.R., Macdonald, P.S. De Geest, S., Handle with care: a scoping 
review on frailty as a concept and its usefulness in solid organ transplantation. Transplantation 
Reviews. 2017:31(3):218-224. 
Mcdonagh, J., Martin, L., Ferguson, C., Jha, S.R., Macdonald, P.S., Davidson, P., & Newton, 
P.J. Frailty assessment instruments in heart failure: a systematic review. European Journal of 
Cardiac Nursing. 2017:17(1):23-35. 
Editorials 
Jha, S.R., Mcdonagh, J., Ferguson, C., Macdonald, P.S., & Newton, P.J., Commentary 
response: Frailty, not just about old people: Reply to Smith GD & Kydd A (2017) Getting care 
of older people right: the need for appropriate frailty assessment? Journal of Clinical Nursing, 
2017:26 (23-24). (Attached as Appendix 10). 
Book Chapter 
Newton. P.J., Davidson, P.M., Ivynian, S.E., Jha, S.R. Living with Chronic Illness and 
Disability 3rd edition: Chapter 21 Chronic Heart Failure. eBook ISBN: 9780729542616. 
Conference Abstracts 
Montgomery, E., Macdonald, P., Newton, P., Jha, SR et al., Frailty as a Predictor of 
Prognostic Outcomes in Patients with Interstitial Lung Disease Referred for Lung 
Transplantation. Journal of Heart and Lung Transplantation. International Society of Heart 
and Lung Transplant (ISHLT), 2018:37(4):S165. Nice, France. 
S, Offen, Jha, S.R. et. al., Frailty Predicts Mortality After Heart Transplantation. Journal of 
Heart and Lung Transplantation. International Society of Heart and Lung Transplant 
(ISHLT), 2018. 37(4):S49. Nice, France.  
Montgomery, E., Macdonald, P., Newton, P., Jha, SR et al., Reversibility of Frailty after Lung 
Transplantation. Journal of Heart and Lung Transplantation. International Society of Heart 
and Lung Transplant (ISHLT), 2018. 37(4):S249. Nice, France. 
Jha, S.R. et. al., Twitter as a tool for knowledge translation in #frailty research: A snapshot 
report. Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR), 
2017. Adelaide, Australia. 
McDonagh, J., Prichard, R., Jha, S.R., Furguson, C., Macdonald, P.S., & Newton, P.J. Frailty 
is highly prevalent among inpatients and outpatients with heart failure according to two frailty 
measurement instruments. ANZSSFR, 2017. Adelaide, Australia. 
Prichard, R., Goodall, S, Macdonald, P.S., J,. Zhao, Jha, S.R., Davidson, P.M., McDonagh, 
J., Newton, P.J & Hayward, C.S., Frailty is associated with reduced patient reported quality 
of life in advanced heart failure patients and clinicians are poor at identifying it. ANZSSFR, 
2017. Adelaide, Australia. 
Wilhelm K, Jha S.R. & Macdonald P.S. Adding depression and cognitive function to 'frailty' 
increases prediction of prognosis in advanced heart failure. WPA XVII World Congress of 
Psychiatry, Berlin 2017. 
 9 
Prichard, R., Jha, S.R., McDonagh, J., Zhao, F., Goodall, S., Davidson, P.M., Macdonald, 
P.S., Hayward, C.S., & & Newton, P.J. Correlating frailty with patient reported quality of life 
in a cohort of advanced heart failure patients undergoing transplant assessment. Journal of 
Frailty and Ageing. ICFSR, 2017.  
McDonagh, J., Martin, L., Furguson, C., Jha, S.R., Macdonald, P.S., Davidson, P.M., & 
Newton, P.J.  How is frailty measured in individuals with heart failure? A systematic review. 
Journal of Frailty and Ageing. Journal of Frailty and Ageing. ICFSR, 2017. 
Montgomery, E., Macdonald, P.S.,… Jha, S.R. (last author). The Prevalence and Prognostic 
Significance of Frailty in Patients with Advanced Lung Disease Referred for Lung 
Transplantation. The Journal of Heart and Lung Transplantation. Vol. 35, Issue 4, S29, 2016. 
ISHLT, 2016. 
McDonagh, J., Ferguson, C., Jha, S.R., et. al., Frailty in hospitalized heart failure patients 
predicts death and rehospitalisation at 6 month. Journal of Frailty and Ageing. ICFSR, 
2016:5(1). 
Ivynian S, DiGiacomo M, Jha, S.R., Crossley C, Newton P. Care-seeking decisions for 
worsening symptoms in Heart Failure: a qualitative metasynthesis. Heart, Lung and 
Circulation. CSANZ. 2015:24(6):S419, 2015.  
 10 
Awards granted as part of this thesis 
 
UTS Doctoral Scholarship – University of Technology Sydney 
Transplant Society of Australia and New Zealand (TSANZ): Travel Grant 
Transplant Society of Australia and New Zealand (TSANZ): Young Investigator 
Award: Top Clinical Presentation - Runner up 
Cardiac Society of Australia and New Zealand (CSANZ) Heart Failure Council 
Travel Grant 
Health Services and Practice Research Student Development Award (HSP) 
UTS Research Student Forum: Best Oral Presentation 




Certificate of original authorship ................................................................................. ii 
Acknowledgements ..................................................................................................... iii 
Anthology of publications and presentations ............................................................... v 
Publications associated with this thesis ....................................................................... v 
Accepted abstracts for oral presentation as part of this thesis .................................... vi 
Accepted abstracts for poster presentation as part of this thesis ................................ vii 
Subsidiary Output ..................................................................................................... viii 
Awards granted as part of this thesis ........................................................................... x 
Contents ...................................................................................................................... xi 
List of Tables............................................................................................................. xiv 
List of Figures ............................................................................................................ xv 
List of Appendices .................................................................................................... xvi 
Abbreviations ........................................................................................................... xvii 
Abstract ................................................................................................................... xviii 
Recommendations from this thesis ........................................................................... xxi 
CHAPTER ONE Background ..................................................................................... 2 
1.1 What is Frailty? ...................................................................................................... 2 
1.2 Frailty in cardiovascular disease ............................................................................ 3 
1.3 Frailty in advanced heart failure ............................................................................ 3 
1.4 Frailty in heart transplantation ............................................................................... 4 
1.5 PhD project............................................................................................................. 6 
1.5.1 Environment ................................................................................................ 6 
1.5.2 Hypothesis ................................................................................................... 6 
1.5.3 Study 1: Systematic review ......................................................................... 6 
1.5.4 Study 2, 3 & 4: Observational Cohort Study ............................................... 6 
1.6 References ............................................................................................................. 9 
CHAPTER TWO Frailty in advanced heart failure: A Systematic Review  .......... 12 
2.1 Preamble ............................................................................................................. 12 
2.2 Abstract ............................................................................................................... 13 
2.3 Introduction ......................................................................................................... 14 
2.4 Methods .............................................................................................................. 14 
2.4.1 Literature search ........................................................................................ 14 
2.5 Results ................................................................................................................. 14 
2.5.1 Study selection ........................................................................................... 14 
2.5.2 Frailty in chronic heart failure ................................................................... 15 
2.6 Discussion ........................................................................................................... 19 
 12 
2.7 Conclusion .......................................................................................................... 22 
2.8 References ........................................................................................................... 23 
CHAPTER THREE The prevalence and prognostic significance of frailty in 
patients with advanced heart failure referred for heart transplantation  ............. 26 
3.1 Preamble ............................................................................................................. 26 
3.2 Abstract ............................................................................................................... 27 
3.3 Introduction ......................................................................................................... 28 
3.4 Methods .............................................................................................................. 29 
3.4.1 Study Population ....................................................................................... 29 
3.4.2 Frailty assessment ...................................................................................... 30 
3.4.3 Assessment of Cognitive impairment and Depression .............................. 31 
3.4.4 Assessment of heart failure severity .......................................................... 31 
3.4.5 Statistical analysis ..................................................................................... 31 
3.5 Results ................................................................................................................. 32 
3.5.1 Prevalence of frailty................................................................................... 32 
3.5.2 The impact of frailty on clinical outcome and actuarial survival .............. 35 
3.5.3 The impact of frailty on survival in relation to other prognostic variables36 
3.5.4 The impact of frailty on BTT VAD outcomes .......................................... 36 
3.5.5 The impact of frailty on heart transplant outcomes ................................... 38 
3.6 Discussion ........................................................................................................... 39 
3.7 Limitations .......................................................................................................... 41 
3.8 Conclusion .......................................................................................................... 41 
3.9 References ........................................................................................................... 42 
CHAPTER FOUR Cognitive impairment improves the predictive validity of 
physical frailty for mortality in patients with advanced heart failure referred for 
heart transplantation ................................................................................................ 45 
4.1 Preamble ............................................................................................................. 45 
4.2 Abstract ............................................................................................................... 46 
4.3 Introduction ......................................................................................................... 47 
4.4 Methods .............................................................................................................. 48 
4.4.1 Study population ........................................................................................ 48 
4.4.2 Measures of Frailty .................................................................................... 48 
4.5 Assessment of heart failure severity ................................................................... 49 
4.5.1 Outcome measures ..................................................................................... 49 
4.5.2 Statistical analysis ..................................................................................... 49 
4.6 Results ................................................................................................................. 51 
4.6.1 Prevalence of frailty................................................................................... 51 
4.6.2 Frailty measures and survival .................................................................... 53 
 13 
4.6.3 Impact of frailty on survival in relation to other prognostic variables ...... 56 
4.6.4 Physical Frailty, Cognitive frailty and BTT-VAD outcomes .................... 56 
4.6.5 Physical frailty, cognitive frailty and heart transplantation outcomes ...... 58 
4.7 Discussion ........................................................................................................... 59 
4.7.1 Study Limitations ...................................................................................... 60 
4.8 Conclusion .......................................................................................................... 60 
4.9 References ........................................................................................................... 61 
CHAPTER FIVE Reversibility of frailty after bridge-to-transplant ventricular 
assist device implantation or heart transplantation .............................................. 64 
5.1 Preamble ............................................................................................................. 64 
5.2 Abstract ............................................................................................................... 65 
5.3 Introduction ......................................................................................................... 66 
5.4 Methods .............................................................................................................. 67 
5.4.1 Study population ........................................................................................ 67 
5.4.2 Frailty, cognition and depression assessment ............................................ 67 
5.4.3 Hand grip strength ..................................................................................... 68 
5.4.4 Assessment of heart failure severity .......................................................... 68 
5.4.5 Outcome measures ..................................................................................... 69 
5.4.6 Statistical analysis ..................................................................................... 69 
5.5 Results ................................................................................................................. 70 
5.5.1 Frailty prevalence ...................................................................................... 70 
5.5.2 Frailty and post-intervention outcomes ..................................................... 72 
5.5.3 Reversibility .............................................................................................. 76 
5.6 Discussion ........................................................................................................... 78 
5.7 Conclusion .......................................................................................................... 80 
5.8 References ........................................................................................................... 81 
CHAPTER SIX Exegesis ......................................................................................... 84 
6.1 Introduction ......................................................................................................... 84 
6.2 Publication review and discussion ...................................................................... 84 
6.3 Future Research .................................................................................................. 86 
6.4 Recommendations from this thesis ..................................................................... 90 
6.5 Study limitations ................................................................................................. 91 
6.6 Conclusion .......................................................................................................... 92 
6.7 References ........................................................................................................... 93 
Acknowledgements .................................................................................................... 95 
Appendices ................................................................................................................. 96 
 14 
List of Tables 
Table 1: Summary of included articles on frailty in patients with heart failure ........ 17 
Table 2: Frailty Phenotype based on 5 physical domains with a possible score of 0 or 
1 for each domain ....................................................................................................... 30 
Table 3: Baseline demographics of study population stratified by frailty status ....... 34 
Table 4: Outcomes post-MCS Implantation stratified by Frailty .............................. 37 
Table 5: Outcomes post-heart transplantation stratified by Frailty ............................ 38 
Table 6: The 5 domains of physical frailty (PF) and additional 2 domains of the 
modified frailty measures with a possible score of 0 or 1 for each domain............... 50 
Table 7: Baseline patient demographics stratified by different frailty measures ....... 52 
Table 8: Outcomes post-BTT-VAD implant by frailty .............................................. 57 
Table 9: Outcomes post-heart transplantation stratified by physical & cognitive 
Frailty ......................................................................................................................... 58 
Table 10: The 5 domains of physical frailty with a possible score of 0 or 1 for each 
domain ........................................................................................................................ 68 
Table 11: Patient demographics by physical frailty ................................................... 71 
Table 12 Post-VAD outcomes by physical frailty ..................................................... 73 




List of Figures 
Figure 1: What is frailty? ............................................................................................. 2 
Figure 2: phenotypic interplay between frailty and advanced heart failure ................. 4 
Figure 3: Recipient age distribution. ............................................................................ 5 
Figure 4: Percent of Patients Bridged with Mechanical Circulatory Support by Year 
and Device Type .......................................................................................................... 5 
Figure 5: Thesis by publication – overall structure ...................................................... 8 
Figure 6: Flow chart of the article search on frailty in heart failure .......................... 15 
Figure 7: Outcome of all patients referred for heart transplantation .......................... 29 
Figure 8: Prevalence of frailty stratified by NYHA Class ......................................... 32 
Figure 9: Relationship between frailty and body mass index .................................... 33 
Figure 10: Actuarial Survival curves for frail and non-frail patients ......................... 35 
Figure 11: Consort diagram illustrating the derivation and outcome of the study 
population ................................................................................................................... 70 
Figure 12: Post-intervention survival ......................................................................... 72 
Figure 13: Follow-up frailty among the BTT-VAD/HTx subgroup .......................... 74 
Figure 14: Changes in frailty score and handgrip strength for patient’s frail pre-VAD
 .................................................................................................................................... 76 
Figure 15: Changes in frailty score and handgrip strength for patient’s frail pre-HTx
 .................................................................................................................................... 77 
Figure 16: VAD independent and responsive frailty ................................................. 88 
Figure 17: VAD outcomes based on relative proportion of dependent/independent 







Throughout this thesis table and figure numbers have been updated from their original 
published version as to maintain sequential appearance throughout in the document. 
 16 
List of Appendices 
Appendix 1: Heart and Lung Frailty Assessment Form ............................................ 96 
Appendix 2: Montreal Cognitive Assessment (MOCA) Form .................................. 97 
Appendix 3: DMI-10 Assessment Form .................................................................... 98 
Appendix 4: Abstracts accepted for oral presentation as part of this thesis (n=10) ... 99 
Appendix 5: Accepted abstracts for poster presentation as part of this thesis (N=6)
 .................................................................................................................................. 112 
Appendix 6: Jha SR et al., Frailty in advanced heart failure: a systematic review. 
Heart Fail Rev. 2015 ................................................................................................ 118 
Appendix 7: Jha SR et al., The prevalence and prognostic significance of frailty in 
patients with advanced heart failure referred for heart transplantation, 
Transplantation, 2016. ............................................................................................. 126 
Appendix 8: Howard J. Eisen Commentary. ............................................................ 134 
Appendix 9: Jha SR et al., Cognitive impairment improves the predictive validity of 
physical frailty for mortality in patients with advanced heart failure referred for heart 
transplantation, Journal of Heart and Lung Transplantation, 2016. ....................... 136 
Appendix 10: Jha SR et al., Reversibility of frailty after bridge-to-transplant 
ventricular assist device implantation or heart transplantation, Transplantation 
Direct, 2017. ............................................................................................................ 144 
Appendix 11: S Jha et al. Commentary response: Frailty, not just about old people: 
Reply to Smith GD & Kydd A (2017) Getting care of older people right: the need for 




AHF  advanced heart failure 
BMI  body mass index 
CAD  coronary artery disease 
CI  cardiac index 
DMI-10 Depression in Medical Illness-10 
FP  Fried Phenotype 
GFR  glomerular filtration rate 
HTx  heart transplantation 
LOS  length of stay 
LVAD  left ventricular assist device 
LVEF  left ventricular ejection fraction 
MCS  mechanical circulatory support 
MoCA  Montreal Cognitive Assessment 
MPAP  mean pulmonary artery pressure 
NYHA  New York Heart Association 
PAWP  pulmonary artery wedge pressure 
RAP  right arterial pressures 
Se  serum 
SHARE-FI Survey of Health, Ageing and Retirement in Europe – Frailty Index 






Frailty research within advanced heart failure (AHF) is a nascent concept. Frailty is 
defined as an increased vulnerability to stressors in response to an individual’s 
declining physiological reserve. As physiological reserves naturally decline with 
advancing age, frailty is considered a geriatric syndrome. While the significance of 
frailty is well entrenched within geriatric medicine, the impact of frailty among other 
specialties is only emerging. The increased survival of an ageing highly co-morbid 
populace of heart failure patients alongside the expanding use of invasive surgical 
interventions, has propelled frailty exploration into the forefront of cardiovascular 
research. This thesis by publication represents the first set of studies to explore the 
impact of frailty in patients with advanced heart failure referred for heart 
transplantation. 
Aim 
As the age of patients being referred, listed and transplanted has steadily risen over 
the last two decades, the overall aim of this thesis was to objectively identify these 
older high-risk patients. Four distinct and interrelated publications make up this thesis, 
each with a different objective: 
Study 1: A systematic review to identify the contemporary understanding of frailty in 
patients with AHF. 
Study 2: To identify the impact of physical frailty among patients with AHF referred 
for heart transplantation. 
Study 3: To identify if the addition of cognitive impairment, depression or both to the 
physical measure of frailty improves its predictive capacity. 
Study 4: To identify if frailty pre-intervention reverses post-intervention.  
Method 
Study 1 - Systematic Review: A review of the key databases was conducted from 
2004 – 2014 including the key search terms ‘frail elderly’ and ‘heart failure’. The 
following electronic databases were searched: Medline, Cumulative Index for Nursing 
and Allied Health (CINAHL) and Academic search complete, with reference lists 
being manually searched. Articles were included if frailty was assessed using a valid 
measuring tool in a population with a confirmed diagnosis of advanced heart failure.  
Study 2, 3 & 4 - Observational cohort study. In 2013 all patients referred for heart 
transplantation were assessed for frailty, cognitive impairment and depression. Frailty 
was assessed using Fried’s Frailty Phenotype (FP). As part of this measure five 
functional domains were measured: Weakness, physical inactivity, exhaustion, 
slowness and reduced appetite. If three or more domains are present from the five, a 
patient was identified as frail and less than three denotes no frailty. Cognitive 
impairment was assessed using the Montreal Cognitive Assessment (MoCA). A 
MoCA score of 26 or less was indicative of cognitive impairment. The Depression in 
Medical Illnesses (DMI-10) tool was used to identify depression. A DMI score greater 
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than 9 is indicative of depression. Patient demographics and markers of disease 
severity were obtained. Among those undergoing either bridge to transplant 
ventricular assist device implantation (BTT-VAD) or heart transplantation (HTx), 
post-interventional outcomes (intubation time, ICU stay and hospital length of stay) 
were examined. Overall survival and post-interventional survival were explored. For 
those identified as frail pre-intervention, frailty was re-assessed at least 2 months post-
intervention for syndrome reversal. 
Results 
Study 1 - Systematic Review: The search yielded a total of 393 articles with 8 articles 
being selected for review. The prevalence of frailty among those with AHF was high, 
ranging from 18-54%. The Frailty Phenotype and Geriatric assessments tools were the 
most common frailty measures utilised; high rates of co-morbidity, hospitalisation and 
mortality were identified. 
Observational cohort studies: 
Study 2 - 120 patients (83M; age 53±12 years, range 16-73; LVEF 27±14%) 
underwent frailty assessment. 39/120 (33%) were assessed as  frail. Frailty was 
associated with NYHA Class IV heart failure, lower body mass index, elevated intra-
cardiac filling pressures, lower cardiac index, anaemia, hypoalbuminemia, 
hyperbilirubinemia, cognitive impairment and depression (all ρ < 0.05). Frailty status 
was independent of age, gender, heart failure duration, left ventricular ejection fraction 
or renal function. Frailty was an independent predictor of increased all-cause 
mortality: one year actuarial survival was 79±5% in the non-frail group compared with 
only 54±9% for the frail group (p < 0.005). 
Study 3 - 156 patients (109M; age 53±13 years; LVEF 27±14%) underwent 
assessment of frailty. Inclusion of cognitive impairment or depression or both to the 
definition of physical frailty (i.e. PF+MoCA, or PF+DMI or PF+MoCA+DMI; Frail 
≥ 3) increased the proportion classified as frail: from 33% using PF to 42% with 
“cognitive frailty” (PF+MoCA). Twenty eight patients died during follow-up prior to 
ventricular assist device (VAD) implantation or HTx. Frailty was associated with 
significantly lower VAD- and HTx-free survival, with cognitive frailty best capturing 
early mortality: 12 month survival for non-frail and frail cohorts was 81 + 5% vs 58 + 
10% (p < 0.02) using PF and 85 + 5% vs 56 + 9% (p < 0.002) using cognitive frailty. 
Combining DMI with PF or cognitive frailty did not strengthen the relationship 
between frailty and mortality. 
Study 4 - 100 patients underwent frailty assessment prior to surgical intervention: 40 
(21 non-frail, 19 frail) BTT-VAD and 77 (60 non-frail, 17 frail) HTx - including 17 of 
the 40 BTT-VAD supported patients. Frail patients had lower survival (63±10% 
versus 94±3% at one year, p=0.012) and experienced significantly longer ICU (11 
versus 5 days, p=0.002) and hospital (49 versus 25 days, p=0.003) length of stay after 
surgical intervention compared with non-frail patients. Twelve of 13 frail patients 
improved their frailty score after VAD (4.0±0.8 to 1.4 ± 1.1, p < 0.001) and 12/13 frail 
patients improved their frailty score after HTx (3.2±0.4 to 0.9±0.9, p < 0.001). Hand-
grip strength and depression improved post-intervention. Only a slight improvement 
in cognitive function was seen post-intervention. 
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Conclusion 
The initial hypothesis was that frailty in this population would provide an ideal 
measure of vulnerability among older transplant referred patients. While this 
hypothesis was rejected, frailty was found to be an age-indiscriminate measure of 
patient vulnerability. The studies presented as part of this thesis demonstrate that 
frailty is highly prevalent among people referred for heart transplantation, being frail 
pre-interventions independently increases the risk of early mortality but in those 
patients that survive the early periods post intervention, frailty can reverse. 
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Recommendations from this thesis 
 
At the conclusion of this thesis, there were 3 main suggested recommendations for 
future research to improve clinical practice in this space. 
Recommendation 1 
It is recommended that frailty not be subjectively identified by visual appearance (i.e. 
“eye-ball-test”/“end-of-the-bed-test”), and that validated HF-specific frailty screening 
tools should be incorporated as part of the standard care for all referred patients 
undergoing heart transplant 
Recommendation 2 
Further research is needed to enable us to differentiate between VAD-responsive 
frailty and VAD-independent frailty. Once able to determine which listed frail patients 
are likely to be responsive to VAD-implantation, making the clinical decision to 
prioritise VAD-implantation should be recommended. The investigation of 
metabolomics profiling in this area may provide the key answers, and warrants piloting 
research. 
Recommendation 3 
The impact of frailty pre-habilitation among those with advanced heart failure needs 
to be evaluated. It is probable that an exercise-based intervention would be effective 
in reducing non-cardiac induced frailty among referred patients. This however 
represents a gap in the evidence and is a high-priority area for further research. 
